Background/Aims Non-alcoholic fatty liver disease (NAFLD) has become a major concern in Korea since its emergence as a dominant cause of chronic liver disease. However, no study has explored its prevalence in adults under 30 years of age. Therefore, we performed a cross-sectional study to investigate the prevalence of NAFLD in Korean men in their early 20s.
Methods We collected data of 596,359 Korean soldiers who participated in a health examination between January 2015 and July 2021. A total of 571,872 individuals were analyzed after excluding those with missing data and hepatitis B antigen positivity. Hepatic steatosis was determined using the hepatic steatosis index (HSI). Participants with HSI >36 were considered to have NAFLD.
Results All participants were men, and the mean age was 20.9±1.3 years. Of the 571,872 participants screened, 77,020 (13.47%) were classified as having NAFLD. The prevalence of NAFLD consistently increased from 2015 to 2021 (10.66% vs. 16.44%, P<0.001). Increases from 2015 to 2021 were also noted in the prevalence of hypercholesterolemia, hyperglycemia, and hypertension (P<0.001 for all). The mean body mass index also increased from 23.3±3.0 kg/m2 to 23.9±3.1 kg/m2 between 2015 and 2021 (P<0.001).
Conclusions The prevalence of NAFLD and of other metabolic dysfunctions in Korean men in their early 20s increased from 2015 to 2021.
Citations
Citations to this article as recorded by
PNPLA3 I148M is unrelated to HCC occurrence but associates with poorer tumor differentiation in Korean MASLD: a prospective cohort of 562 patients Jaejun Lee, Dong Yeop Lee, Jung Hoon Cha, Hee Sun Cho, Keungmo Yang, Hyun Yang, Mi Young Byun, Seok Keun Cho, Seong Wook Yang, Si Hyun Bae, Pil Soo Sung Journal of Liver Cancer.2026; 26(1): 147. CrossRef
Predictive factors of MASLD in young adults: A systematic review and narrative synthesis Moirangthem Jeena Devi, Anita Malhotra, Piyush Ranjan, Manisha Sabharwal, Aditi Verma, Nikita Madan, Archana Kumari, Maroof A. Khan, Upendra Baitha, Bindu Prakash Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2026; 20(5): 103435. CrossRef
Surgically confirmed severe endometriosis is associated with lower risk of steatotic liver disease: Evidence of estrogen‐linked hepatic–reproductive crosstalk Jung Hyun Park, Keungmo Yang, Hyun Yang, Si Hyun Bae, Mee‐Ran Kim, Jaejun Lee International Journal of Gynecology & Obstetrics.2026;[Epub] CrossRef
Association Between Thyroid Function Indicators and Metabolic‐Associated Fatty Liver Disease: Effect Modification by Iodine Nutritional Status Wei Huang, Jiang Yao, Yunzhen Shi, Heyong Huang, Suraiya Saleem International Journal of Endocrinology.2026;[Epub] CrossRef
Steatotic Liver Disease Predicts Lower Likelihood of LDLR Gene Mutations in Young Korean Patients with Suspected Familial Hypercholesterolemia Chang In Han, Sung Hyun Cho, Keungmo Yang, Hyun Yang, Si Hyun Bae, Jaejun Lee Journal of Obesity & Metabolic Syndrome.2026; 35(3): 370. CrossRef
Emerging Indices Outperform Traditional Fibrosis Scores in Young Metabolic Dysfunction‐Associated Steatotic Liver Disease Across Divergent Screening Goals Ahlim Lee, Chang In Han, Keungmo Yang, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Jaejun Lee Journal of Gastroenterology and Hepatology.2026; 41(9): 2925. CrossRef
Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4–based two-step algorithms for MASLD Jaejun Lee, Hyun Yang, Si Hyun Bae, Sunhong Yoo, Soon Woo Nam, Jiwoon Yoon, Jung Hyun Kwon, Soon Kyu Lee Hepatology.2026;[Epub] CrossRef
PNPLA3 Is Associated With Hepatocellular Carcinoma, While a Five‐Variant Polygenic Risk Score Shows Limited Discrimination in Korean Patients With MASLD Jaejun Lee, Jung Hoon Cha, Hee Sun Cho, Hyun Yang, Mi Young Byun, Seok Keun Cho, Seong Wook Yang, Si Hyun Bae, Seung Up Kim, Su Jong Yu, Pil Soo Sung Journal of Gastroenterology and Hepatology.2026;[Epub] CrossRef
Appendicular skeletal muscle mass is associated with metabolic dysfunction-associated steatotic liver disease severity in young men: a cross-sectional and longitudinal study Jaejun Lee, Jinson So, Chang In Han, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Do Seon Song Hepatology International.2025; 19(1): 181. CrossRef
Differential Exercise Requirements for Nonalcoholic Fatty Liver Disease Resolution Across Age Groups: A Longitudinal Study of Korean Military Officers Jaejun Lee, Dong Yeup Lee, Jae Hyeop Jung, Eunkyoung Bae, Jeong A. Yu, Hyun Yang Journal of Physical Activity and Health.2025; 22(3): 323. CrossRef
Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults Jaejun Lee, Chang In Han, Dong Yeup Lee, Pil Soo Sung, Si Hyun Bae, Hyun Yang Gut and Liver.2025; 19(1): 116. CrossRef
A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease Michelle Thuy Nguyen, Andrew Lian, Frederick Timothy Guilford, Vishwanath Venketaraman Biomedicines.2025; 13(3): 644. CrossRef
Effect of treadmill walking on cardiometabolic risk factors and liver function markers in older adults with MASLD: a randomized controlled trial Jiyoun Kim, Sungju Lee, Yong-Seok Jee BMC Sports Science, Medicine and Rehabilitation.2025;[Epub] CrossRef
Association Between Nonalcoholic Fatty Liver Disease and Risk of Early-onset Colorectal Cancer Seulji Kim, Jin-Hyung Jung, Kyungdo Han, Seong-Joon Koh, Jong Pil Im, Byeong Gwan Kim, Joo Sung Kim, Hyun Jung Lee Clinical Gastroenterology and Hepatology.2025; 23(13): 2550. CrossRef
Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis Seidamir P. Tabaeian, Aziz Rezapour, Samad Azari, Mariano Martini, Maryam Saran, Meysam Behzadifar, Saeed Shahabi, Abdollah Sayyad, Ali Tahernejad, N.L. Bragazzi, S.J. Ehsanzadeh, Masoud Behzadifar Journal of Clinical and Experimental Hepatology.2024; 14(1): 101209. CrossRef
Impact of Overseas Deployment on Fatty Liver and Metabolic Diseases Among Korean Soldiers Chang In Han, Jaejun Lee Military Medicine.2024; 189(7-8): e1621. CrossRef
Impact of Korean Military Service on the Prevalence of Steatotic Liver Disease: A Longitudinal Study of Pre-enlistment and In-Service Health Check-Ups Jaejun Lee, Jae Hyeop Jung, Sung Jun Choi, Beomman Ha, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Jeong-A Yu Gut and Liver.2024; 18(5): 888. CrossRef
Serum uric acid and nonalcoholic fatty liver disease Jia Fan, Dongxu Wang Frontiers in Endocrinology.2024;[Epub] CrossRef
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease Ho Soo Chun, Minjong Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐Ho Lee, Ji‐Hye Kim, Seung Up Kim Liver International.2023; 43(3): 608. CrossRef
Global incidence and prevalence of nonalcoholic fatty liver disease Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah Clinical and Molecular Hepatology.2023; 29(Suppl): S32. CrossRef
Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models Dong Yun Kim, Kyu Sik Chung, Jun Yong Park, Heon Yung Gee Biomedicine & Pharmacotherapy.2023; 161: 114445. CrossRef
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra Clinical and Molecular Hepatology.2023; 29(Suppl): S286. CrossRef
Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis Yi-wen Shi, Jian-Gao Fan Clinical and Molecular Hepatology.2023; 29(Suppl): S228. CrossRef
Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management Anja Geerts, Sander Lefere Clinical and Molecular Hepatology.2023; 29(Suppl): S276. CrossRef
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease Hyunwoo Oh, Won Sohn, Yong Kyun Cho Clinical and Molecular Hepatology.2023; 29(Suppl): S261. CrossRef
Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017 Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park Diabetes & Metabolism Journal.2023; 47(3): 347. CrossRef
Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD Yun Kyu Lee, Bo Kyung Koo, Sae Kyung Joo, Dong Hyeon Lee, Heejoon Jang, Jee Won Chai, Myoung Seok Lee, Si Won Jang, Young Ho So, Jeong Hwan Park, Mee Soo Chang, Won Kim Alimentary Pharmacology & Therapeutics.2023; 58(3): 322. CrossRef
Analysis of risk factors related to nonalcoholic fatty liver disease: a retrospective study based on 31,718 adult Chinese individuals Ganggang Wang, Xiaowei Shen, Yicun Wang, Huanhua Lu, Hua He, Xiaoliang Wang Frontiers in Medicine.2023;[Epub] CrossRef
A survey on the awareness, current management, and barriers for non-alcoholic fatty liver disease among the general Korean population Jun-Hyuk Lee, Jang Han Jung, Huiyul Park, Joo Hyun Oh, Sang Bong Ahn, Eileen Laurel Yoon, Dae Won Jun Scientific Reports.2023;[Epub] CrossRef
Muscle Mass Adjusted for Body Weight Is Associated with Significant Liver Fibrosis in Young Adults with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Korean Military Hospital Jaejun Lee, Seongjoo Na, Taeyun Kim, Seong-Woo Lee, Myoung Jung Kim, Chang In Han, Si Hyun Bae Journal of Obesity & Metabolic Syndrome.2023; 32(3): 279. CrossRef
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations Soon Sun Kim, Jae Youn Cheong Clinical and Molecular Hepatology.2022; 28(4): 802. CrossRef
Allogreffe de cellules souches hématopoïétiques dans la myélofibrose : sélection des patients, préparation pré-greffe et harmonisation des pratiques (SFGM-TC) Gaëlle Vertenoeil, Deborah Desmier, Stavroula Masouridi-Levrat, Clémence Médiavilla, Laetitia Souchet, Michael Loschi, Marie Robin, Léonardo Magro, Jérôme Cornillon Bulletin du Cancer.2026;[Epub] CrossRef
Mielofibrosis como causa de hipertensión portal no cirrótica Juan José Quiroz-Leyva, Edgar Fermín Yan-Quiroz, José Richard Tenazoa-Villalobos Revista de Gastroenterología del Perú.2026; 46(2): 215. CrossRef
Navigating ‘grey areas’ and challenges during evaluation of transplant eligibility in specific myelofibrosis populations: a perspective on behalf of the Chronic Malignancies Working Party of the EBMT Nicola Polverelli, Juan Carlos Hernández-Boluda, Nico Gagelmann, Carmelo Gurnari, Michele Malagola, Fernando Barroso Duarte, Vaneuza A. M. Funke, Caterina Zerbi, Donal P. McLornan Bone Marrow Transplantation.2025; 60(1): 10. CrossRef
Role of Portosystemic Shunt and Portal Vein Stent in Managing Portal Hypertension Due to Hematological Diseases Ji Hoon Kim, Suho Kim, Hee-Chul Nam, Chang Wook Kim, Jae-Sung Yoo, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ho-Jong Chun, Sung-Eun Lee, Jung-Suk Oh, Pil Soo Sung Cureus.2024;[Epub] CrossRef
The Value of Follow‐Up Liver Stiffness Changes Measured by Virtual Touch Quantification Elastography for Predicting Recurrence of Gastroesophageal Varices after Endoscopic Injection Sclerotherapy on Cirrhotic Patients Yayang Duan, Jinfei Zhang, Min Fan, Derun Kong, Chaoxue Zhang, Jose Celso Ardengh Gastroenterology Research and Practice.2024;[Epub] CrossRef
Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR‐ABL negative myeloproliferative neoplasms Marta Davidson, Florence Wong, Mostafa Atri, Hassan Sibai, Dawn Maze, Verna Cheung, Jeannie Callum, Eshetu G. Atenafu, Vikas Gupta American Journal of Hematology.2023;[Epub] CrossRef
Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis Jacinta Perram, David M. Ross, Donal McLornan, Krisstina Gowin, Nicolas Kröger, Vikas Gupta, Clinton Lewis, Nico Gagelmann, Nada Hamad American Journal of Hematology.2022; 97(11): 1464. CrossRef
First
Prev
